Infectious Diseases Related News
Llama nanobodies may protect against all variants of COVID
An international research team has discovered that immune particles in llama blood may provide robust protection from all variants of COVID and can potentially...
What is polio? Everything you NEED to know
What is polio? Health Europa brings you everything you need to know about the disease, its origins, symptoms, how you can catch it, and...
Typhoid fever bacteria increasingly resistant to antibiotics
Stanford University-led research has identified that bacteria causing typhoid fever are becoming progressively resistant to the antibiotics used to combat the infection.
The novel research...
Long COVID in children can last more than two months
A new extensive study suggests that long COVID symptoms in children aged up to 14 years can persist for at least two months following...
1,000 genes discovered that may cause severe COVID-19
Scientists from the University of Sheffield and Stanford University have identified more than 1,000 genes that may increase the risk of severe COVID-19 infection.
Previous...
14% of the global population may have tick-borne Lyme disease
A groundbreaking analysis has revealed that more than 14% of the world’s population has or has previously had tick-borne Lyme disease.
Researchers have performed a...
Inhaled aerosol vaccines may provide the most robust disease protection
Research conducted at McMaster University has identified that inhaled aerosol vaccines may provide more potent and longer-lasting protection from infectious diseases than nasal sprays.
Nasal...
New chemical process may help design mRNA vaccines for all diseases
A Japanese research team has pioneered a new all-chemical process that may significantly advance vaccine technology, enabling scientists to design mRNA vaccines for a...
COVID-19 may increase psychiatric disorder risk by 25%
A new study performed at Oregon State University has discovered that people infected with COVID-19 are at an elevated risk of developing a psychiatric...
New coronavirus identified is common among bank voles
A team of scientists based in Sweden has made a groundbreaking discovery, identifying a new coronavirus that is prevalent in the bank vole population.
The...
Over 100 monkeypox cases confirmed in the UK
The UK Health Security Agency (UKHSA) has revealed that there are now over 100 confirmed monkeypox cases in the UK.
The latest data from the...
The detergent-disinfectant wipe that reduces MRSA acquisitions by 55%
From infection prevention specialists GAMA Healthcare, Clinell Universal Wipes reduced MRSA acquisitions in a large teaching hospital in the UK.
In 2021, new guidelines were...
Monkeypox symptoms are potentially reduced with antiviral medications
An analysis of seven monkeypox cases in the UK between 2018 and 2021 has revealed that some antiviral drugs may alleviate monkeypox symptoms.
The retrospective...
Innovative AI technology identifies COVID-19 lung damage
Scientists at King Abdullah University of Science and Technology (KAUST) have developed an Artificial Intelligence (AI) tool that can accurately diagnose COVID-19 lung damage.
The...
Clinell disinfectants provide robust protection against monkeypox virus
As cases of the monkeypox virus are becoming increasingly prevalent across the globe, research from GAMA Healthcare demonstrates how its Clinell range of products...
100,000 child deaths from respiratory syncytial virus in 2019
Findings from a global study published in The Lancet have highlighted the dire landscape of respiratory syncytial virus (RSV) around the world, estimating that...
What increases the risk of long Covid symptoms?
A Japanese research team at Hiroshima University have identified what characteristics make a person more likely to develop long Covid symptoms.
Long Covid symptoms are...
Pfizer Covid vaccine prevented over 110,000 deaths in the US
A new study has revealed that the Pfizer Covid vaccine prevented over 110,000 deaths since its widespread implementation in the US.
The Pfizer Covid vaccine...
Enhancing the efficacy of cancer vaccines and antibody drug conjugates
In its quest to optimise treatment for cancer and infectious diseases, Defence Therapeutics illustrates how its groundbreaking Accum technology elevates the performance of vaccines...
Vaccine for Epstein-Barr virus to undergo a clinical trial
The National Institute of Allergy and Infectious Diseases (NIH) has announced performing an early-stage clinical trial to assess an Epstein-Barr virus (EBV) vaccine.
The Phase...